Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes
Uthman O, Chen Y
Record ID 32011000042
English
Authors' recommendations:
Recent systematic reviews pooling results from randomised controlled trials suggest a modest reduction of approximately 0.2% in HbA1c level in patients undertaking SMBG compared to no SMBG.Interpretation of pooled effect estimates from these reviews is complicated by mixed methodological quality, differences in patient populations, implementation and frequency of SMBG and standard of care in control groups between trials.Recently published high quality trials have demonstrated the lack of significant benefit of SMBG compared to standard care in certain patient groups.Studies evaluating cost-effectiveness of SMBG compared to standard care have reported conflicting findings, which reflect different effectiveness data used in the calculations.
Details
Project Status:
Completed
URL for project:
http://www.nhshealthquality.org/nhsqis/files/ClinicalGovernance_EN26ClinicalAndCostEffectivenessOfSMBG_JAN09.pdf
Year Published:
2009
URL for published report:
http://www.nhshealthquality.org/nhsqis/controller?p_service=Content.show&p_applic=CCC&pContentID=5253
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland
MeSH Terms
- Blood Glucose
- Blood Glucose Self-Monitoring
- Hypoglycemic Agents
Contact
Organisation Name:
Quality Improvement Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
NHS Quality Improvement Scotland (NHS QIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.